In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
about
A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in PregnancyAntibiotics in the clinical pipeline at the end of 2015.Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.What's old is new: Reconfiguring known antibiotics to fight drug resistance.
P2860
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activity of solithrom ...... tant Streptococcus agalactiae.
@en
In vitro activity of solithrom ...... tant Streptococcus agalactiae.
@nl
type
label
In vitro activity of solithrom ...... tant Streptococcus agalactiae.
@en
In vitro activity of solithrom ...... tant Streptococcus agalactiae.
@nl
prefLabel
In vitro activity of solithrom ...... tant Streptococcus agalactiae.
@en
In vitro activity of solithrom ...... tant Streptococcus agalactiae.
@nl
P2093
P2860
P50
P356
P1476
In vitro activity of solithrom ...... stant Streptococcus agalactiae
@en
P2093
Arnaldo Caruso
Carlo Bonfanti
Prabhavathi Fernandes
P2860
P304
P356
10.1128/AAC.02210-13
P407
P577
2013-12-30T00:00:00Z